Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Atul Verma, MD, head of cardiology at McGill University Health Centre in Montreal, Canada

News | Atrial Fibrillation

New Ablation Technology Found Safe, Effective for Atrial Fibrillation

March 6, 2023 — A new ablation technology known as pulsed field ablation was successful at eliminating episodes of ...

March 06, 2023

News | ACC

Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-class Medication Shows Promise in Treating Rare Heart Lung Condition

March 6, 2023 — In findings presented from the STELLAR Phase III Trial during the American College of Cardiology’s 2023 ...

March 06, 2023

Virtual Care Team-Guided Strategy was found to optimize GDMT for hospitalized HF patients according to results of the multi-center IMPLEMENT-HF Trial presented at ACC 23/WCC during a March 6 Featured Clinical Research session.

News | ACC

Virtual Care Team-Guided Strategy Optimizes GDMT for Hospitalized HF Patients in IMPLEMENT-HF Trial, According to Multi-Center Study Presented at ACC 23

March 7, 2023 — A virtual care team-guided strategy for guideline-directed medical therapy (GDMT) optimization was found ...

March 06, 2023

Braden Manns, MD, professor of medicine at the University of Calgary

News | Cardiovascular Clinical Studies

Eliminating Copays for Preventive Drugs Does Not Reduce Cardiac Events

March 5, 2023 — Providing medications for chronic diseases—for example, cholesterol-lowering, blood pressure and diabete ...

March 05, 2023

Brian A. Ference, MD, MPhil, MSc, professor and director of translational therapeutics at the University of Cambridge in the United Kingdom

News | Artificial Intelligence

AI Provides Personalized Guidance Based on Inherited Risk of Heart Disease

March 5, 2023 — Researchers demonstrated that a causal artificial intelligence (AI) system can accurately quantify how ...

March 05, 2023

Salim Virani, MD, PhD, staff cardiologist at the Michael E. DeBakey VA Medical Center in Houston, vice provost for research and professor at the Aga Khan University in Karachi, Pakistan, and staff at The Texas Heart Institute/Baylor College of Medicine.

News | Peripheral Artery Disease (PAD)

Targeted Reminders Increase Prescriptions for High-Intensity Statins

March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...

March 05, 2023

Tor Biering-Sørensen, MD, MSc, MPH, PhD, professor, Center for Translational Cardiology and Pragmatic Randomized Trials, Copenhagen University Hospital,

News | ACC

Linking Flu Vaccination to Potential Cardiovascular Benefits Gets More People to Roll Up Their Sleeves

March 5, 2023 — Making a connection between the flu and the risk of subsequent heart problems significantly increased fl ...

March 05, 2023

Amrita Mukhopadhyay, MD, cardiologist and clinical investigator at NYU Grossman School of Medicine in New York City

News | Heart Failure

Prescribing of Key Heart Failure Medications Improved with Tailored Digital Alerts

March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...

March 05, 2023

John K. Forrest, MD, director of interventional cardiology and structural heart disease at Yale University School of Medicine

News | Cardiovascular Clinical Studies

Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years

March 5, 2023 — The number of deaths and disabling strokes among patients at low surgical risk who were treated with tra ...

March 05, 2023

Nearly 40% risk reduction seen with intravascular imaging compared with angiography alone

News | Intravascular Imaging

Stenting With Close Look Inside Blood Vessel Improves Outcomes in Patients with Complex Coronary Artery Disease

March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular ...

March 05, 2023

In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.

News | Stents

Immediate Complete Revascularization as Safe and Effective as Staged Procedure in Treating Multi-Vessel Disease

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

March 05, 2023

COAPT trial demonstrates long-term benefits of transcatheter procedure in high-risk patients with heart failure

News | Structural Heart

Minimally Invasive Mitral Valve Repair Reduces Hospitalizations and Deaths

March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...

March 05, 2023

Newer technique is equally safe and effective when performed by experienced surgeons, according to investigators

News | Cardiovascular Clinical Studies

March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac ...

March 05, 2023

The Opening Showcase of the American College of Cardiology's Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, featured comments from Ed Fry, MD, ACC President, shown here, the event Chair and World Heart Federation President. the 3-day global gathering of cardiologists is taking place March 4-6 in New Orleans, LA.

Feature | ACC | Christine Book

Important Clinical Trial Outcomes, the Evolution of Cardiac ICU and Young Authors Take Center Stage for Global Gathering of Cardiologists in New Orleans ACC.23/WCC

March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the American ...

March 04, 2023

News | ACC

STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports

March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus ...

March 04, 2023